|
|
Blood, 1 January 2009, Vol. 113, No. 1, pp. 214-223.
Prepublished online as a Blood First Edition Paper on September 29, 2008; DOI 10.1182/blood-2008-07-168286.
Previous Article | Next Article 
Submitted July 14, 2008
Accepted August 15, 2008
Depletion of autoreactive immunological memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
Tobias Alexander*, Andreas Thiel, Oliver Rosen, Gero Massenkeil, Arne Sattler, Siegfried Kohler, Henrik Mei, Hartmut Radtke, Erika Gromnica-Ihle, Gerd-Rudiger Burmester, Renate Arnold, Andreas Radbruch, and Falk Hiepe
German Rheumatism Research Center, Berlin, Germany
Regenerative Immunology and Aging, Berlin-Brandenberg Center for Regenerative Therapies (BCRT), Berlin, Germany
Department of Hematology and Oncology, Charite Universitatsmedizin, Berlin, Germany
Institute for Transfusion Medicine, Charite Universitatsmedizin, Berlin, Germany
Rheuma-Klinik Berlin-Buch, Berlin, Germany
Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin, Berlin, Germany
* Corresponding author; email: tobias.alexander{at}charite.de.
Clinical trials have indicated that immunoablation followed by autologous hematopoietic stem cell transplantation (ASCT) has the potential to induce long-term clinical remission in patients with refractory systemic lupus erythematosus (SLE), but the mechanisms have remained unclear. We now report the results of a single-center prospective study of long-term immune reconstitution following ASCT in seven adult patients with SLE.
The long-term clinical remissions observed in these patients are accompanied by the depletion of autoreactive immunologic memory, reflected by the disappearance of pathogenic anti-dsDNA antibodies and protective antibodies in serum and a fundamental resetting of the adaptive immune system. The latter comprises recurrence of CD31+ CD45RA+ CD4+ T cells (recent thymic emigrants) with a doubling in absolute numbers compared to age-matched healthy controls at the 3yr-follow-up (p=0.016), the regeneration of thymic-derived FoxP3+ regulatory T cells, and normalization of peripheral TCR repertoire usage. In a similar manner, responders exhibited normalization of the previously disturbed B cell homeostasis with numeric recovery of the naive B cell compartment within 1 year after ASCT. These data are the first to demonstrate that both depletion of autoreactive immunologic memory and a profound resetting of the adaptive immune system are required to re-establish self-tolerance in SLE. Our clinical trial is registered at www.clinicaltrials.gov under the ID NCT00742300.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Resetting the clock
- Gabor G. Illei
Blood 2009 113: 2-3.
[Full Text]
[PDF]
|
|